Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 17/20 | 0.52 |
| ▸ | MMP13 | P45452 | 15/20 | 0.52 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.46 |
| ▸ | MMP9 | P14780 | 4/20 | 0.43 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | MMP3 | P08254 | 3/20 | 0.43 |
| ▸ | MMP8 | P22894 | 3/20 | 0.43 |
| ▸ | MMP14 | P50281 | 3/20 | 0.43 |
| ▸ | MMP7 | P09237 | 2/20 | 0.43 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.41 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.41 |
| ▸ | MMP10 | P09238 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7208148 | 0.92 | MMP1 (0.52) | MMP1MMP13ADAMTS5MMP9MMP2 | |
| SCHEMBL25364 | 0.90 | MMP1 (0.52) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL7209196 | 0.89 | MMP1 (0.53) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL7208630 | 0.81 | MMP13 (0.56) | MMP1MMP13ADAMTS5MMP9MMP2 | |
| SCHEMBL7213095 | 0.80 | MMP1 (0.49) | MMP1MMP13ADAMTS5MMP9MMP2 | |
| SCHEMBL7209180 | 0.79 | MMP1 (0.57) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL7209154 | 0.78 | MMP1 (0.47) | MMP1MMP13MMP9MMP2MMP3 | |
| Hydroxyamine SCHEMBL7514521 | 0.75 | MMP1 (0.76) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL27450137 | 0.75 | MMP1 (0.65) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL12076423 | 0.74 | MMP1 (0.79) | MMP1MMP13MMP9MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1181285-B1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PROD INC (US) | 2003-10-08 | — | — | EP | claimed |
| US-6342521-B1 | DRUGS FOR TREATMENT OF ARTHRITIS | PFIZER INC. | 2002-01-29 | — | — | US | claimed |
| EP-1181285-B1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PROD INC (US) | 2003-10-08 | — | — | EP | disclosed |
| EP-1181285-A2 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | Pfizer Products Inc. (US) | 2002-02-27 | — | — | EP | disclosed |
| US-6342521-B1 | DRUGS FOR TREATMENT OF ARTHRITIS | PFIZER INC. | 2002-01-29 | — | — | US | disclosed |
| WO-2000073294-A2 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PRODUCTS INC. (US) | 2000-12-07 | — | — | WO | disclosed |